BioAtla (BCAB) Current Leases (2021 - 2026)

BioAtla's Current Leases history runs 6 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Current Leases rose 181.41% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 181.41% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 70.69% from the prior year.
• Current Leases advanced to $1.6 million in Q1 2026 per BCAB's latest filing, from $1.4 million in the prior quarter.
• Across five years, Current Leases topped out at $1.7 million in Q2 2024 and bottomed at $554000.0 in Q1 2025.
• The 5-year median for Current Leases is $1.5 million (2022), against an average of $1.4 million.
• Across the five-year window, Current Leases tumbled 63.29% in 2025 and jumped 181.41% in 2026, its largest moves.
• Year by year, Current Leases stood at $1.5 million in 2022, then grew by 6.77% to $1.6 million in 2023, then tumbled by 48.52% to $836000.0 in 2024, then soared by 70.69% to $1.4 million in 2025, then climbed by 9.25% to $1.6 million in 2026.
• Per Business Quant, the three latest BCAB Current Leases figures stand at $1.6 million (Q1 2026), $1.4 million (Q4 2025), and $1.2 million (Q3 2025).